T. Rowe Price Associates’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,914,919
Closed -$214M 2732
2020
Q3
$214M Sell
1,914,919
-100
-0% -$11.2K 0.02% 471
2020
Q2
$199M Buy
+1,915,019
New +$199M 0.03% 473